While these two penny stocks have the potential for exceptional returns, they also carry greater risk and volatility.
Investor sentiment remains strong but upcoming tech earnings and an expected interest rate hike may provide more clarity on the short-term outlook for stocks
Will the $11.00 level be a double-top ceiling…or can Acumen Pharmaceuticals build momentum and climb towards its $25.00 IPO price?
The company announced a $100 million stock sale.
September S&P 500 futures (ESU23) are down -0.03%, and September Nasdaq 100 E-Mini futures (NQU23) are down -0.10% this morning as market participants braced for the next round of quarterly reports while...
Here is how Novo Nordisk (NVO) and Acumen Pharmaceuticals, Inc. (ABOS) have performed compared to their sector so far this year.
ABOS earnings call for the period ending June 30, 2022.
CHARLOTTESVILLE, Va. and CARMEL, Ind., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical stage biopharmaceutical...
Model designed to fill need for soluble amyloid beta oligomer reference standards in bioanalytical assays...
CHARLOTTESVILLE, Va. and CARMEL, Ind., July 26, 2022 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical stage biopharmaceutical...